| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.
Authors: Alvarez-Calderon F, Gregory M, Pham-Danis C, Deryckere D, Stevens B, Zaberezhnyy V, Hill A, Gemta L, Kumar A, Kumar V, Wempe M, Pollyea D, Jordan C, Serkova N, Graham D, DeGregori J
Clin Cancer Res, 2015;21(6):1360-72.
Species: Human
Sample Type: Whole Cells
miR-9 is a tumor suppressor in pediatric AML with t(8;21).
Authors: Emmrich, S, Katsman-Kuipers, J E, Henke, K, Khatib, M E, Jammal, R, Engeland, F, Dasci, F, Zwaan, C M, den Boer, M L, Verboon, L, Stary, J, Baruchel, A, de Haas, V, Danen-van Oorschot, A A, Fornerod, M, Pieters, R, Reinhardt, D, Klusmann, J H, van den Heuvel-Eibrink, M M
Leukemia, 2014;28(5):1022-32.
Species: Human
Sample Type: whole cells
Sox2 expression in breast tumours and activation in breast cancer stem cells.
Authors: Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R, Martin AG
Oncogene, 2012;31(11):1354-65.
Species: Human
Sample Type: Whole Cells
Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
Authors: Tai Y, Chang B, Kong S, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao J, Cagnetta A, Cea M, Sellitto M, Zhong M, Wang Q, Acharya C, Carrasco D, Buggy J, Elias L, Treon S, Matsui W, Richardson P, Munshi N, Anderson K
Blood, 2012;120(9):1877-87.
Species: Mouse
Sample Type: Whole Cells
|
